Gilead Sciences
GILD
#118
Rank
NZ$305.42 B
Marketcap
NZ$246.32
Share price
-2.14%
Change (1 day)
29.08%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2026 (TTM): NZ$18.33 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are NZ$29.73 Billion. In 2025 the company made an earning of NZ$16.56 Billion, an increase over its 2024 earnings that were of NZ$1.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$18.33 B10.71%
2025 NZ$16.56 B1319.86%
2024 NZ$1.16 B-89.94%
2023 NZ$11.59 B17.97%
2022 NZ$9.83 B-29.77%
2021 NZ$13.99 B395.99%
2020 NZ$2.82 B-67.66%
2019 NZ$8.72 B-33.84%
2018 NZ$13.18 B-42.35%
2017 NZ$22.87 B-20.87%
2016 NZ$28.90 B-21.06%
2015 NZ$36.62 B45.8%
2014 NZ$25.11 B253.01%
2013 NZ$7.11 B16.51%
2012 NZ$6.10 B-1.07%
2011 NZ$6.17 B-6.71%
2010 NZ$6.61 B11.75%
2009 NZ$5.92 B29.5%
2008 NZ$4.57 B19.11%
2007 NZ$3.83 B-455.74%
2006 -NZ$1.08 Billion-154.93%
2005 NZ$1.96 B76.99%
2004 NZ$1.10 B-266.16%
2003 -NZ$0.67 Billion-638.24%
2002 NZ$0.12 B31.5%
2001 NZ$94.37 M-242.15%
2000 -NZ$66.4 Million-40.2%
1999 -NZ$0.12 Billion31.85%
1998 -NZ$84.21 Million8.73%
1997 -NZ$77.44 Million27.22%
1996 -NZ$60.87 Million
1994 -NZ$58 Million26.57%
1993 -NZ$45.83 Million46.49%
1992 -NZ$31.28 Million362.5%
1991 -NZ$6.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$43.92 B 142.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$17.90 B-1.28%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$10.10 B-44.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$52.62 B 190.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.36 B-15.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$2.74 B-84.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$1.96 B-89.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$8.55 B-52.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$22.23 B 22.60%๐Ÿ‡บ๐Ÿ‡ธ USA